We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LLYVA:NASDAQLiberty Live Holdings, Inc. - Series A Liberty Live Group Analysis

Data as of 2026-05-26 - not real-time

$95.93

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Liberty Live Holdings is trading at $95.93, comfortably above its 20‑day ($93.92), 50‑day ($93.17) and 200‑day ($88.53) simple moving averages, and the MACD line sits bullishly above its signal ($0.89 vs $0.71) with a neutral‑to‑slightly‑positive RSI of 55. Volume is on an increasing trend, supporting the short‑term price momentum, while the 30‑day volatility of 31.8% and a beta of 0.85 indicate a stock that moves sharply but less than the broader market. The Fear & Greed Index reads “Extreme Greed,” reflecting strong market optimism despite the mixed fundamentals.
Fundamentally, the company posts a 35% year‑over‑year revenue growth to $398.5 M, yet margins are deeply negative (gross margin 20%, operating margin –26%, profit margin –88%) and earnings per share are –$3.83, leading to a forward P/E of 51.6 versus an industry average of 17. The balance sheet shows $524 M in cash offset by $1.82 B of debt, a negative book value per share (‑$3.45) and zero free cash flow, underscoring significant cash‑burn and valuation concerns.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bullish technical setup with price above key moving averages
  • Increasing volume supporting short‑term momentum
  • Upcoming earnings release that could confirm revenue trajectory

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • High forward P/E (51.6) far above industry norm
  • Sustained negative profitability and cash‑burn
  • Elevated volatility and potential correction toward support at $88.33

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • Negative book value and heavy debt load
  • Lack of dividend and no clear path to profitability
  • Fundamental mismatch between revenue growth and earnings erosion

Key Metrics & Analysis

Financial Health

Revenue Growth35.20%
Profit Margin-88.23%
P/E Ratio51.6
ROA-2.05%
P/B Ratio-27.8
Op. Cash Flow$-21615000
Industry P/E17.0

Technical Analysis

TrendBullish
RSI55.1
Support$88.33
Resistance$99.16
MA 20$93.92
MA 50$93.17
MA 200$88.53
MACDBullish
VolumeIncreasing
Fear & Greed Index91.8

Valuation

GradeOvervalued
TypeGrowth

Risk Assessment

Beta0.85
Volatility31.77%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.